Hrt Financial LP Tela Bio, Inc. Transaction History

Hrt Financial LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$4.39 - $6.36 $93,195 - $135,016	21,229 New	21,229 $99,000
Q1 2023 May 12, 2023	BUY	$9.41 - $12.03 $153,016 - $195,619	16,261 New	16,261 $173,000
Q3 2022 Nov 14, 2022	BUY	$7.36 - $9.15 $101,332 - $125,977	13,768 New	13,768 $117,000
Q4 2021 Feb 14, 2022	SELL	$11.95 - $13.34 $123,335 - $137,682	-10,321 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$12.2 - $15.93 $75,823 - $99,004	-6,215 Reduced 37.58%	10,321 $140,000
Q2 2021 Aug 16, 2021	BUY	$11.7 - $16.11 $193,471 - $266,394	16,536 New	16,536 $266,000

18.3M

759K

100

Ticker TELA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 19,157,600
Market Cap $53.4M
Description
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall recon...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.